Chargement en cours...
Infección por SARS-CoV-2 y seroprevalencia en pacientes con esclerosis múltiple
INTRODUCTION: The effect of SARS-CoV-2 infection in patients with multiple sclerosis (MS) and the influence of disease-modifying therapies (DMT) for MS on COVID-19 are unknown. To date, patients with MS have not been shown to present greater risk of COVID-19 or more severe progression of the disease...
Enregistré dans:
| Publié dans: | Neurologia |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Sociedad Española de Neurología. Published by Elsevier España, S.L.U.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7973057/ https://ncbi.nlm.nih.gov/pubmed/33812762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nrl.2021.03.005 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|